These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29089645)

  • 1. Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.
    Bae J; Hideshima T; Zhang GL; Zhou J; Keskin DB; Munshi NC; Anderson KC
    Leukemia; 2018 Mar; 32(3):752-764. PubMed ID: 29089645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.
    Bae J; Hideshima T; Tai YT; Song Y; Richardson P; Raje N; Munshi NC; Anderson KC
    Leukemia; 2018 Sep; 32(9):1932-1947. PubMed ID: 29487385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients.
    Bae J; Prabhala R; Voskertchian A; Brown A; Maguire C; Richardson P; Dranoff G; Anderson KC; Munshi NC
    Leukemia; 2015 Jan; 29(1):218-29. PubMed ID: 24935722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
    Bae J; Smith R; Daley J; Mimura N; Tai YT; Anderson KC; Munshi NC
    Clin Cancer Res; 2012 Sep; 18(17):4850-60. PubMed ID: 22753586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.
    Tiriveedhi V; Sarma NJ; Subramanian V; Fleming TP; Gillanders WE; Mohanakumar T
    Hum Immunol; 2012 Jan; 73(1):11-6. PubMed ID: 22074997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
    Suda T; Tsunoda T; Daigo Y; Nakamura Y; Tahara H
    Cancer Sci; 2007 Nov; 98(11):1803-8. PubMed ID: 17784873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.
    Akiyama Y; Komiyama M; Nakamura Y; Iizuka A; Oshita C; Kume A; Nogami M; Miyata H; Ashizawa T; Yoshikawa S; Kiyohara Y; Yamaguchi K
    Cancer Immunol Immunother; 2012 Dec; 61(12):2311-9. PubMed ID: 22707303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma.
    Bae J; Carrasco R; Lee AH; Prabhala R; Tai YT; Anderson KC; Munshi NC
    Leukemia; 2011 Oct; 25(10):1610-9. PubMed ID: 21660045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
    Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M
    Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
    Bae J; Tai YT; Anderson KC; Munshi NC
    Br J Haematol; 2011 Nov; 155(3):349-61. PubMed ID: 21902685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs.
    Mimura K; Kono K; Southwood S; Fikes J; Takahashi A; Miyagawa N; Sugai H; Fujii H
    Cancer Immunol Immunother; 2006 Nov; 55(11):1358-66. PubMed ID: 16435129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma.
    Bae J; Song W; Smith R; Daley J; Tai YT; Anderson KC; Munshi NC
    Br J Haematol; 2012 Jun; 157(6):687-701. PubMed ID: 22533610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
    Yamaguchi H; Tanaka F; Ohta M; Inoue H; Mori M
    Clin Cancer Res; 2004 Feb; 10(3):890-6. PubMed ID: 14871964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer.
    Sawada Y; Komori H; Tsunoda Y; Shimomura M; Takahashi M; Baba H; Ito M; Saito N; Kuwano H; Endo I; Nishimura Y; Nakatsura T
    Oncol Rep; 2014 Mar; 31(3):1051-8. PubMed ID: 24366042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8
    Bae J; Samur M; Richardson P; Munshi NC; Anderson KC
    Leukemia; 2019 Sep; 33(9):2208-2226. PubMed ID: 30872779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Programmed Death Ligand 1-derived Peptides Capable of Inducing Cancer-reactive Cytotoxic T Lymphocytes From HLA-A24+ Patients With Renal Cell Carcinoma.
    Minami T; Minami T; Shimizu N; Yamamoto Y; De Velasco M; Nozawa M; Yoshimura K; Harashima N; Harada M; Uemura H
    J Immunother; 2015 Sep; 38(7):285-91. PubMed ID: 26261892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel human leukocyte antigen-A*11:01-restricted cytotoxic T-lymphocyte epitopes derived from osteosarcoma antigen papillomavirus binding factor.
    Li D; Toji S; Watanabe K; Torigoe T; Tsukahara T
    Cancer Sci; 2019 Apr; 110(4):1156-1168. PubMed ID: 30767336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.
    Kobayashi J; Torigoe T; Hirohashi Y; Idenoue S; Miyazaki A; Yamaguchi A; Hiratsuka H; Sato N
    J Transl Med; 2009 Jan; 7():1. PubMed ID: 19123955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A.
    Osawa R; Tsunoda T; Yoshimura S; Watanabe T; Miyazawa M; Tani M; Takeda K; Nakagawa H; Nakamura Y; Yamaue H
    J Biomed Biotechnol; 2012; 2012():848042. PubMed ID: 22778556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel HLA-A 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.
    Yoshimura M; Tada Y; Ofuzi K; Yamamoto M; Nakatsura T
    Oncol Rep; 2014 Jul; 32(1):33-9. PubMed ID: 24842630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.